3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Terminated
1
Recruiting
1
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Triple Negative Breast Neoplasms
2
Colorectal Neoplasms
2
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Postoperative Complications
1
Pancreatic Neoplasms
1
Overweight
1
Ovarian Neoplasms
1
Obesity
1
Neoplasms
1
Motor Activity
1
Lung Neoplasms
1
Leukemia
1
Hypothalamic Neoplasms
1
Glioblastoma
1
Gastrointestinal Neoplasms
1
GastroEsophageal Cancer
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Intraductal, Noninfiltrating
1
Burkitt Lymphoma
1
Breast Carcinoma In Situ
1
Advanced Malignant Solid Neoplasm
1
Interventions
Exercise
36
Nutritional Status
5
Control Groups
4
Resistance Training
3
High-Intensity Interval Training
3
lime
2
Vitamin D
2
Standard of Care
2
Preoperative Exercise
2
Dosage Forms
2
Diet
2
tislelizumab
1
pembrolizumab
1
oncomodulin
1
diacetamate
1
blueberry extract
1
beta-Glucans
1
Whey Proteins
1
Wearable Electronic Devices
1
Walking
1
Transcranial Direct Current Stimulation
1
Tea
1
Tablets
1
TEMPO
1
Spermine Synthase
1
Roflumilast
1
Rehabilitation
1
Radiotherapy
1
Probiotics
1
Physical Therapy Modalities
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Motor Activity
×
Diet Therapy
×
Clear all
NCT07042724
2025-06-29
STARLighT
Universita di Verona
Phase NA
Recruiting
324 enrolled